Anthera Pharmaceuticals, Inc. ANTH

Full chart Compare
Set alert

Price alert · ANTH

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00 52-week range 0.001
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $1.70MIncome Tax Benefit → Expenses: $1.92MExpenses → Selling, General & Admin: $11.07MExpenses → Research & Development: $46.25MGross Profit → Expenses: $98.75KRevenue → Gross Profit: $98.75KRevenue → Cost of Revenue: $46.25KNet Loss → Expenses: $53.60MOther Income$1.70MIncome Tax Benefit$1.92MGross Profit$98.75KNet Loss$53.60MCost of Revenue$46.25KExpenses$57.32MSelling, General & Admin$11.07MResearch & Development$46.25MRevenue$145.00K

Latest period ending Dec 31, 2017 · select a line to chart its full history

Annual income statement

ANTH annual income statement
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
36.43M57.32M38.43M28.46M28.25M
28.59M46.51M33.50M21.84M21.68M
7.94M11.07M7.57M6.62M6.56M
-36.43M-57.18M-35.24M-28.46M-28.25M
-26.87M-55.52M-35.22M-29.60M-30.86M
-29.38M-66.44M-35.22M-29.60M-30.86M
-29.38M-66.44M-35.22M-29.60M-30.86M
-26.87M-55.52M-35.22M-29.60M-30.86M
-2.86-12.87-7.91-10.88-13.52
-2.86-12.87-7.91-10.88-13.52
-2.86-12.87-7.91-10.88-13.52
-26.87M-55.52M-35.22M-28.55M-28.26M
-26.87M-55.52M-35.22M-28.55M-28.26M
2.50M10.91M000
10.28M5.16M4.45M2.72M2.28M
10.28M5.16M4.45M2.72M2.28M